These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6197313)

  • 1. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
    Sander GE; Kastin AJ; Giles TD
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1301-3. PubMed ID: 6131437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
    Hahn EF; Itzhak Y; Nishimura S; Johnson N; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):846-50. PubMed ID: 2416910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs.
    Given MB; Sander GE; Giles TD
    Life Sci; 1986 Apr; 38(14):1299-303. PubMed ID: 3959755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-allylnormetazocine: hemodynamic actions and inhibition of leucine-enkephalin hemodynamic activity in conscious dogs.
    Given MB; Sander GE; Lowe RF; Giles TD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):850-6. PubMed ID: 3204519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
    Galetta S; Hahn EF; Nishimura S; Pasternak GW
    Life Sci; 1987 Aug; 41(6):783-7. PubMed ID: 2441221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
    Williams CL; Bodnar RJ; Clark JE; Hahn EF; Burks TF; Pasternak GW
    J Pharmacol Exp Ther; 1988 Apr; 245(1):8-12. PubMed ID: 2452249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.
    Hahn EF; Carroll-Buatti M; Pasternak GW
    J Neurosci; 1982 May; 2(5):572-6. PubMed ID: 6176696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation.
    Trujillo KA; Belluzzi JD; Stein L
    Behav Brain Res; 1989 Jun; 33(2):181-8. PubMed ID: 2548531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the cardiovascular response to systemic intravenous administration of leucine-enkephalin in the conscious dog.
    Giles TD; Sander GE
    Peptides; 1983; 4(2):171-5. PubMed ID: 6137809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endorphins on heart rate and blood pressure in adult dogs.
    Haddad GG; Jeng HJ; Lai TL
    Am J Physiol; 1986 May; 250(5 Pt 2):H796-805. PubMed ID: 3518492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate antagonists: central sites of action in suppressing water intake of the rat.
    Brown DR; Holtzman SG
    Brain Res; 1981 Sep; 221(2):432-6. PubMed ID: 7284781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine.
    Larson AA; Armstrong MJ
    Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice.
    Ramabadran K
    Life Sci; 1982 Sep 20-27; 31(12-13):1253-6. PubMed ID: 6183549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-Ketonaltrexone and 10-ketooxymorphone.
    Archer S; Seyed-Mozaffari A; Ward S; Kosterlitz HW; Paterson SJ; McKnight AT; Corbett AD
    J Med Chem; 1985 Jul; 28(7):974-6. PubMed ID: 2409281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
    Evans RG; Ludbrook J; Van Leeuwen AF
    J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat.
    Koob GF; Pettit HO; Ettenberg A; Bloom FE
    J Pharmacol Exp Ther; 1984 May; 229(2):481-6. PubMed ID: 6716270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure.
    Sakamoto S; Liang CS
    Circulation; 1989 Oct; 80(4):1010-5. PubMed ID: 2551535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.